Search Results 1641-1650 of 17020 for Green Birth Control
The purpose of this clinical research study is to learn if pazopanib when given in combination with topotecan can help to control sarcomas. The safety of ...
Contact the study team to discuss study eligibility and potential participation. Show more eligibility criteria. Subject population (children, adults, groups):.
... controls); Human Epidermal Growth Factor Receptor 2 (HER2) negative as per American Society of Clinical Oncology - College of American Pathologists (ASCO/CAP) ...
Participation eligibility · Chronologic age > 2 months regardless of gestational age at birth · Expected PICU stay > 3 calendar days as predicted by the ...
Individuals regarded as belonging to a vulnerable population (e.g., prisoners). Antibiotic exposure within two weeks of stool microbiome collection ...
Controls can be friends or cousins of the anti-synthetase positive myositis ... Controls should be without a recognized autoimmune disease or ILD. Able ...
The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.